Strides Pharma Annual Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2022	Mar-2021	Mar-2020	Mar-2019	Mar-2018
Gross Sales	3070.25	3315.87	2751.97	2178.37	2845.12
Excise Duty	--	--	--	--	--
Net Sales	3070.25	3315.87	2751.97	2178.37	2845.12
Other Operating Income	--	--	--	--	--
Other Income	131.99	108.72	53.11	367.29	689.73
Total Income	3202.24	3424.59	2805.08	2545.66	3534.85
Total Expenditure	3444.99	2778.86	2433.74	2045.97	2494.51
PBIDT	(242.76)	645.73	371.34	499.69	1040.34
Interest	176.74	150.07	155.72	79.29	196.24
PBDT	(419.50)	495.67	215.62	420.40	844.10
Depreciation	233.01	206.29	173.70	117.39	154.03
Minority Interest Before NP	--	--	--	--	--
Tax	(150.44)	21.45	28.01	28.92	48.51
Deferred Tax	(27.82)	10.20	(16.68)	(55.78)	(42.83)
Reported Profit After Tax	(474.25)	257.73	30.60	329.87	684.39
Minority Interest After NP	(14.04)	(10.71)	(5.80)	5.26	19.87
Net Profit after Minority Interest	(460.21)	268.44	36.39	324.61	664.52
Extra-ordinary Items	(243.83)	38.37	(37.89)	11.60	(17.14)
Adjusted Profit After Extra-ordinary item	(216.38)	230.07	74.28	313.01	681.66
EPS (Unit Curr.)	(51.28)	29.96	4.06	36.25	74.25
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	25	140	30	20
Equity	89.79	89.68	89.57	89.55	89.50
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	(7.91)	19.47	13.49	22.94	36.57
PBDTM(%)	(13.66)	14.95	7.83	19.30	29.67
PATM(%)	(15.45)	7.77	1.11	15.14	24.05